DIN BELLE; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for DIN BELLE; David.The latest application filed is for "catechol o-methyltransferase activity inhibiting compounds".

Company Profile

6.7.17

DIN BELLE; David - Espoo FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Catechol O-methyltransferase Activity Inhibiting Compounds App 20220047540 - AHLMARK; Marko ; et al.	2022-02-17
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20210347765 - DIN BELLE; David ; et al.	2021-11-11
4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile Solvates And Crystalline Forms Thereof App 20210347728 - DIN BELLE; David	2021-11-11
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors Grant 11,098,032 - Din Belle , et al. August 24, 2	2021-08-24
Catechol O-methyltransferase Activity Inhibiting Compounds App 20200352898 - AHLMARK; Marko ; et al.	2020-11-12
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20200299280 - DIN BELLE; David ; et al.	2020-09-24
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors Grant 10,717,726 - Din Belle , et al.	2020-07-21
Catechol O-methyltransferase Activity Inhibiting Compounds App 20200009103 - AHLMARK; Marko ; et al.	2020-01-09
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20190359601 - DIN BELLE; David ; et al.	2019-11-28
Catechol O-methyltransferase Activity Inhibiting Compounds App 20190029990 - Ahlmark; Marko ; et al.	2019-01-31
Catechol O-methyltransferase Activity Inhibiting Compounds App 20170165219 - AHLMARK; Marko ; et al.	2017-06-15
Catechol O-methyltransferase activity inhibiting compounds Grant 9,458,128 - Ahlmark , et al. October 4, 2	2016-10-04
Catechol O-methyltransferase Activity Inhibiting Compounds App 20150218124 - Ahlmark; Marko ; et al.	2015-08-06
2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,809,536 - Din Belle , et al. August 19, 2	2014-08-19
2,3-dihydrobenzo[1,4] Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20140179926 - DIN BELLE; David ; et al.	2014-06-26
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,697,723 - Din Belle , et al. April 15, 2	2014-04-15
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20130281486 - DIN BELLE; David ; et al.	2013-10-24
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases Grant 8,492,549 - Din Belle , et al. July 23, 2	2013-07-23
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20120035210 - Din Belle; David ; et al.	2012-02-09
Aryl Piperazine And Their Use As Alpha2c Antagonists App 20110262352 - Din Belle; David ; et al.	2011-10-27
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20100216836 - Din Belle; David ; et al.	2010-08-26
Polycyclic compounds as potent alpha2-adrenoceptor antagonists App 20070293527 - Din Belle; David ; et al.	2007-12-20
Polycyclic compounds as potent alpha2-adrenoceptor antagonists App 20060094740 - Din Belle; David ; et al.	2006-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.